Zai Lab (ZLAB) Cash from Operations (2018 - 2026)
Zai Lab (ZLAB) posted Cash from Operations of 11912000.0 for Q1 2026, up 54.22% sequentially from 26022000.0 in Q4 2025, and up 80.69% YoY from 6592383.69 in Q1 2025.
Powered by 
Analysis
Zai Lab (ZLAB) Cash from Operations (2018 - 2026) Analysis & Trends
Zai Lab has reported Cash from Operations for 9 years, with the latest figure at 11912000.0 in Q1 2026.
- Quarterly Cash from Operations rose 80.69% year-over-year to 11912000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 101002000.0 (up 45.83% YoY) and the FY2025 annual result came in at 150789000.0, up 29.82% from the prior year.
- Cash from Operations improved to 11912000.0 in Q1 2026 per ZLAB's latest filing, from 26022000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 11912000.0 in Q1 2026 and troughed at 126323000.0 in Q3 2022.
- A 5-year average of 55493529.41 and a median of 55272000.0 in 2023 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2023 and 2024: Cash from Operations jumped 86.35% in 2023, then tumbled 273.86% in 2024.
- Over 5 years, Cash from Operations stood at 109292000.0 in 2022, then surged by 86.35% to 14917000.0 in 2023, then sank by 273.86% to 55769000.0 in 2024, then jumped by 53.34% to 26022000.0 in 2025, then jumped by 54.22% to 11912000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 11912000.0, 26022000.0, and 32044000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -526.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -387.32 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 462.82 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 326.72 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 728.46 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Zai Lab | 2.94 Bn | 2.23 Bn | 58.15 Mn | -63.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -63.41 Mn |
| Mar 31, 2026 | -11.91 Mn |
| Dec 31, 2025 | -26.02 Mn |
| Sep 30, 2025 | -32.04 Mn |
| Jun 30, 2025 | -31.02 Mn |
| Mar 31, 2025 | -61.70 Mn |
| Dec 31, 2024 | -55.77 Mn |
| Sep 30, 2024 | -26.82 Mn |
| Jun 30, 2024 | -42.17 Mn |
| Mar 31, 2024 | -90.11 Mn |
| Dec 31, 2023 | -14.92 Mn |
| Sep 30, 2023 | -55.27 Mn |
| Jun 30, 2023 | -58.70 Mn |
| Mar 31, 2023 | -69.29 Mn |
| Dec 31, 2022 | -109.29 Mn |
| Sep 30, 2022 | -126.32 Mn |
| Jun 30, 2022 | -44.90 Mn |
| Mar 31, 2022 | -87.13 Mn |
| Dec 31, 2021 | -152.99 Mn |
| Sep 30, 2021 | -160.89 Mn |